
Psyence also reported earnings for the second quarter ended Sept. 30.
Psyence also reported earnings for the second quarter ended Sept. 30.
The losses primarily stem from a surge in research and development costs.
Psyence stretched its fiscal runway and paid off all the debt on its balance sheet.
Unpack the industry with the daily cannabis newsletter for business leaders.
Unpack the industry with the daily cannabis newsletter for business leaders.